During the past decade, Azienda Ospedaliera di Padova conducted 189 clinical trials. In the 10-year time frame, 189 clinical trials started and 64 clinical trials were completed, i.e. on average, 33.9% percent of trials that started reached the finish line to date. In the past 5 years, 88 clinical trials started and 45 clinical trials were completed. i.e. 51.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera di Padova" #1 sponsor was "Boehringer Ingelheim" with 15 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 14 trials sponsored, "University of Padova" with 14 trials sponsored, "Azienda Ospedaliera di Padova" with 12 trials sponsored and "Janssen Research & Development, LLC" with 12 trials sponsored. Other sponsors include 226 different institutions and companies that sponsored additional 143 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera di Padova" #1 collaborator was "Azienda Ospedaliera di Padova" with 9 trials as a collaborator, "Associazione Italiana per la Ricerca sul Cancro" with 3 trials as a collaborator, "European Commission" with 3 trials as a collaborator, "Servicio Madrileño de Salud, Madrid, Spain" with 3 trials as a collaborator and "A2F Associates Limited" with 2 trials as a collaborator. Other collaborators include 131 different institutions and companies that were collaborators in the rest 120 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera di Padova" are "Ulcerative Colitis" (14 trials), "Crohn's Disease" (12 trials), "Brain and Central Nervous System Tumors" (8 trials), "Colitis, Ulcerative" (8 trials) and "Crohn Disease" (7 trials). Many other conditions were trialed in "Azienda Ospedaliera di Padova" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera di Padova" are "Drug" (189 trials), "Device" (37 trials), "Other" (35 trials), "Procedure" (22 trials) and "Biological" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (58 trials), "Guselkumab" (8 trials), "radiation therapy" (7 trials), "Dexamethasone" (6 trials) and "etoposide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera di Padova" are 290 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 83 active trials in "Azienda Ospedaliera di Padova". 2 are not yet recruiting, 48 are recruiting, 32 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 149 completed trials in Azienda Ospedaliera di Padova, 2 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera di Padova, 9 "Phase 1" clinical trials were conducted, 88 "Phase 2" clinical trials and 104 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 29 trials that are defined as “Not Applicable".

Azienda Ospedaliera di Padova has several departments that took part in Clinical trials: "Clinica di oncoematologia pediatrica" - 9 trials, "UOC Gastroenterologia" - 8 trials, "Azienda Ospedaliera di Padova; Clinica Neurologica" - 5 trials, "Univ. Di Padova - Dip. Di Pediatria - Unita' Reumatol. Pediatrica" - 3 trials, "Reparto Di Neurologia dell'Osperdale Di Padova" - 2 trials, "Azienda Ospedaliera Padova, U.O.C. Cardiologia" - 2 trials, "Azienda Ospedaliera Padova, Clinica Cardiologica" - 2 trials, "Azienda Ospedaliera di Padova; Dipartimento di Medicina - UOC di Reumatologia" - 2 trials